Nature CommunicationsSystems BiologyPeer-reviewed journal article
Mechanistic origin of drug interactions between translation-inhibiting antibiotics
Abstract
Antibiotics that interfere with translation, when combined, interact in diverse and difficult-to-predict ways. Here, we demonstrate that these interactions can be accounted for by "translation bottlenecks": points in the translation cycle where antibiotics block ribosomal progression. To elucidate the underlying mechanisms of drug interactions between translation inhibitors, we generated translation bottlenecks genetically using inducible control of translation factors that regulate well-defined translation cycle steps. These perturbations accurately mimicked antibiotic action and their interactions, supporting that the interplay of different translation bottlenecks causes these interactions. We further showed that the kinetics of drug uptake and binding together with growth laws allows direct prediction of a large fraction of observed interactions, yet fails for suppression. Simultaneously varying two translation bottlenecks in the same cell revealed how the dense traffic of ribosomes and competition for translation factors results in previously unexplained suppression. This result highlights the importance of "continuous epistasis" in bacterial physiology.
- organism: bacteria (other)
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 56
- FWCI
- 2.67
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A generalized growth law for translation- and transcription-targeting antibiotics captures drug interactions
Natawan Gadjisade, Matteo Mori, Tobias Bollenbach·bioRxiv·Aug 24, 2026
- Minimal biophysical model of combined antibiotic action
B. Kavcic, G. Tkacik, T. Bollenbach·bioRxiv·Apr 18, 2020
- Trans-Translation inhibitors and copper ions synergize for enhanced antibiotic activity
Melissa Vázquez‐Hernández, Huriye Deniz Uzun, … Julia Elisabeth Bandow·bioRxiv·Nov 14, 2024
- A reverse-central-dogma pathway underlies ribosome-antibiotic efficacy and accelerates resistance evolution
- Orthoformimycin inhibits translation elongation by displacing the A-site tRNA and preventing peptide bond formation
A. Schedlbauer, T. Kaminishi, … P. Fucini·bioRxiv·Nov 29, 2021
- Antimicrobial Combination Effects at Sub-inhibitory Doses do not Reliably Predict Effects at Inhibitory Concentrations
Malte Muetter, Daniel C. Angst, … Sebastian Bonhoeffer·bioRxiv·Sep 1, 2026